Apremilast Treatment and Long-Term (156-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Analysis of a Large Database of 3 Phase III, Randomized, Controlled Trials

Gladman DD, Kavanaugh A, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, Mcilraith M, Hu C, Edwards CJ, Birbara CA, Mease PJ (2016)

Publication Type: Conference contribution

Publication year: 2016

Journal

Arthritis and Rheumatology Wiley

Book Volume: 68

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

University of Orléans / Université d'Orléans

France (FR) Toronto Western Hospital

Canada (CA) Celgene Corporation

United States (USA) (US) Schön Klinik Hamburg Eilbek

Germany (DE) Complejo Hospitalario Universitario de Santiago de Compostela

Spain (ES) University Hospital Southampton NHS

United Kingdom (GB) University of California, San Diego

United States (USA) (US) Swedish Medical Center

United States (USA) (US) University of Massachusetts Amherst (UMass)

United States (USA) (US) University of Genova / Università degli Studi di Genova

Italy (IT)

How to cite

APA:

Gladman, D.D., Kavanaugh, A., Gomez-Reino, J.J., Wollenhaupt, J., Cutolo, M., Schett, G.,... Mease, P.J. (2016). Apremilast Treatment and Long-Term (156-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Analysis of a Large Database of 3 Phase III, Randomized, Controlled Trials.

MLA:

Gladman, Dafna D., et al. "Apremilast Treatment and Long-Term (156-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Analysis of a Large Database of 3 Phase III, Randomized, Controlled Trials." 2016.

BibTeX: Download